Bio-Thera Solutions, Ltd. (688177) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bio-Thera Solutions, Ltd.

Why is Bio-Thera Solutions, Ltd. ?

Poor Management Efficiency with a low ROCE of 1.31%

The company has been able to generate a Return on Capital Employed (avg) of 1.31% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of 51.34% and Operating profit at 4.20% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

DEBT-EQUITY RATIO (HY) Highest at 79.01 %
CASH AND EQV(HY) Lowest at CNY 592.24 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 0.89 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -0.19%, its profits have fallen by -4.5%

Below par performance in long term as well as near term

Along with generating -0.19% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Bio-Thera Solutions, Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Bio-Thera Solutions, Ltd.

10.29%

-0.36

40.05%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

51.34%

EBIT Growth (5y)

4.20%

EBIT to Interest (avg)

-179.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.33

Sales to Capital Employed (avg)

0.50

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.31%

ROE (avg)

0.69%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

20.34

EV to EBIT

-27.71

EV to EBITDA

-32.95

EV to Capital Employed

13.55

EV to Sales

15.68

PEG Ratio

Dividend Yield

ROCE (Latest)

-48.90%

ROE (Latest)

-68.60%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY -32.96 MM

NET PROFIT(HY)

Higher at CNY -130.81 MM

RAW MATERIAL COST(Y)

Fallen by -12.66% (YoY

NET SALES(Q)

Highest at CNY 241.7 MM

-4What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 79.01 %

CASH AND EQV(HY)

Lowest at CNY 592.24 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.89 times

Here's what is working for Bio-Thera Solutions, Ltd.

Operating Cash Flow

Highest at CNY -32.96 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

Higher at CNY -130.81 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Profit

At CNY -130.81 MM has Grown at 47.21%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Sales

Highest at CNY 241.7 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 241.7 MM has Grown at 23.51%

over average net sales of the previous four periods of CNY 195.69 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost

Fallen by -12.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Bio-Thera Solutions, Ltd.

Debt-Equity Ratio

Highest at 79.01 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at CNY 592.24 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 0.89 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio